Archives of Gynecology and Obstetrics

, Volume 288, Issue 5, pp 1107–1113 | Cite as

Squamous intraepithelial lesions in HIV-infected women: prevalence, incidence, progression and regression

  • Regis Kreitchmann
  • Halim Bajotto
  • Daila Alena Raenck da Silva
  • Sandra Costa Fuchs
Gynecologic Oncology

Abstract

Purpose

To evaluate the impact of HIV immune depletion, highly active antiretroviral therapy (HAART) and patient characteristics on the occurrence of cervical squamous intraepithelial lesions (SIL).

Methods

A total of 898 HIV-positive women were evaluated at the time of their first Pap smear and 388 of them received additional Pap smears during follow-up in a cohort study. The patients were enrolled from July 1997 to April 2007. Prevalence and incidence of SIL in Pap smears were studied. Progression and regression were evaluated in follow-up of patients presenting low-grade SIL.

Results

Pap smear results at baseline were: 741 normal (82.5 %), 56 atypical squamous cells of indeterminate significance (ASCUS) (6.2 %), 78 low-grade SIL (8.7 %), 22 high-grade SIL (2.4 %), and 1 invasive cervical cancer (0.1 %). SIL cumulative incidence rate was 9.7 %. Progression and regression occurred in 15.9 and 62 %, respectively. Multivariate analysis of CD4 counts ≤200 cells/mm3 (aHR = 2.1; 95 % CI 1.3–3.5; P = 0.004) and age less than 30 years (aHR = 3.2; 95 % CI 1.5–6.8; P = 0.01) or less than 40 years old (aHR = 2.6; 95 % CI 1.2–5.7; P = 0.01) were significantly associated with SIL prevalence. CD4 counts ≤200 cells/mm3 (aHR = 3.0; 95 % CI 1.2–7.2; P = 0.01) and higher viral load counts (for each log increase) were associated with SIL incidence (aHR = 1.4; 95 % CI 1–1.9; P = 0.048).

Conclusions

Prevalence and incidence of SIL in HIV-positive women were associated with severity of HIV disease. Interventions to increase access to Pap smears and further diagnostic tests should be implemented and targeted to HIV-positive women.

Keywords

Cervical intraepithelial neoplasia Vaginal smears HIV 

Notes

Acknowledgments

This study was partially supported by CNPq, Brazilian Ministry of Science and Technology.

Conflict of interest

The authors have nothing to disclose with regard to potential conflicts of interest.

Ethical standard

The study was approved by the IRB of the Hospital Presidente Vargas from the Municipal Health Department of Porto Alegre and all women gave their informed consent to participate.

References

  1. 1.
    INCA/MS (2012) Cancer surveillance data in Brazil http://www.inca.gov.br. Accessed 17 Jan 2013
  2. 2.
    Duerr A, Kieke B, Warren D, Shah K, Burk R, Peipert JF et al (2001) Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol 184(4):584–590PubMedCrossRefGoogle Scholar
  3. 3.
    Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P et al (1999) Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 91(3):226–236PubMedCrossRefGoogle Scholar
  4. 4.
    Davis AT, Chakraborty H, Flowers L, Mosunjac MB (2001) Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): a correlation with HIV viral load and CD4 + count. Gynecol Oncol 80(3):350–354PubMedCrossRefGoogle Scholar
  5. 5.
    Delmas MC, Larsen C, van Benthem B, Hamers FF, Bergeron C, Poveda JD et al (2000) Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women. AIDS 14(12):1775–1784PubMedCrossRefGoogle Scholar
  6. 6.
    Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD (1998) Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 12(12):1459–1464PubMedCrossRefGoogle Scholar
  7. 7.
    Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S et al (2001) The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 15(16):2157–2164PubMedCrossRefGoogle Scholar
  8. 8.
    Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S et al (2001) Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 184(5):547–551PubMedCrossRefGoogle Scholar
  9. 9.
    Schuman P, Ohmit SE, Klein RS, Duerr A, Cu-Uvin S, Jamieson DJ et al (2003) Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 188(1):128–136PubMedCrossRefGoogle Scholar
  10. 10.
    Brazil MoH- (2012) Recommendations for the use of antiretroviral therapy in HIV infected adolescents and adults http://www.aids.gov.br/sites/default/files/anexos/publicacao/2012/52140/consenso_adulto2012_principais_mudancas_pdf_11946.pdf. Accessed 17 Jan 2013
  11. 11.
    National Cancer Institute Workshop (1989) The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 262(7):931–934CrossRefGoogle Scholar
  12. 12.
    Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M et al (2002) The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287(16):2114–2119PubMedCrossRefGoogle Scholar
  13. 13.
    Leal EAS, Junior OSL, Guimarães MH, Vitoriano MN, Costa OL, Nascimento TL (2003) Cervical cancer precursor lesions in adolescents and young adult women of Rio Branco-Acre. Rev Bras Ginecol Obstet 25(2):81–86CrossRefGoogle Scholar
  14. 14.
    Silva R, Reis A, Russomano F, Fialho S, Grinsztein B (2003) Cervical intraepithelial lesions among HIV infected patients. DST J bras Doenças Sex Transm 15(3):16–20Google Scholar
  15. 15.
    Massad LS, Evans CT, Minkoff H, Watts DH, Strickler HD, Darragh T et al (2004) Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus. Obstet Gynecol 104(5 Pt 1):1077–1085PubMedCrossRefGoogle Scholar
  16. 16.
    INCA/MS (2003) Brazilian nomeclature for Pap smear test results and management guidelines http://www.aprp.org.br/arquivos/Texto_Nomenclatura_brasileira_citopatologia_28%5B1%5D.07.03-versao_final.doc. Accessed 15 Feb 2013
  17. 17.
    INCA/MS (2006) Brazilian nomeclature for Pap smear test results and management guidelines http://www.inca.gov.br/inca/Arquivos/Titulos/Nomenclatura_colo_do_utero.pdf. Accessed 15 Feb 2013
  18. 18.
    BHIVA (2008) British HIV Association guidelines for HIV-associated malignancies. HIV Med 9:336–338CrossRefGoogle Scholar
  19. 19.
    Melgaco FG, Rosa ML, Augusto EF, Haimuri JG, Jacintho C, Santos LS et al (2010) Human papillomavirus genotypes distribution in cervical samples from women living with human immunodeficiency virus. Arch Gynecol Obstet 283(4):809–817PubMedCrossRefGoogle Scholar
  20. 20.
    Lodi CT, Michelin MA, Lima MI, Teixeira NC, Adad SJ, Murta EF et al (2010) Factors associated with recurrence of cervical intraepithelial neoplasia after conization in HIV-infected and noninfected women. Arch Gynecol Obstet 284(1):191–197PubMedCrossRefGoogle Scholar
  21. 21.
    Nappi L, Carriero C, Bettocchi S, Herrero J, Vimercati A, Putignano G (2005) Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence, and progression, in treated and untreated women. Eur J Obstet Gynecol Reprod Biol 121(2):226–232PubMedCrossRefGoogle Scholar
  22. 22.
    Holcomb K, Abulafia O, Matthews RP, Chapman JE, Borges A, Lee YC et al (1999) The significance of ASCUS cytology in HIV-positive women. Gynecol Oncol 75(1):118–121PubMedCrossRefGoogle Scholar
  23. 23.
    Duerr A, Paramsothy P, Jamieson DJ, Heilig CM, Klein RS, Cu-Uvin S et al (2006) Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Infect Dis 42(6):855–861PubMedCrossRefGoogle Scholar
  24. 24.
    Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D (2007) 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 11(4):223–239PubMedCrossRefGoogle Scholar
  25. 25.
    Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D (2007) 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197(4):346–355PubMedCrossRefGoogle Scholar
  26. 26.
    Auge AP, Piato S, Frade AB, Paes RP, Moura CMC, Santos ALD, Vaz A (2000) Frequency of cervical intraepithelial neoplasia in human immunodeficiency virus-infected women. Rev Bras Ginecol Obstet 22(9):573–577CrossRefGoogle Scholar
  27. 27.
    Melo V, Araújo A, Rio S, Castro L, Azevedo A, Castro M (2003) The most frequent gynecological problems in HIV-infected women. Rev Bras Ginecol Obstet 25(9):661–666CrossRefGoogle Scholar
  28. 28.
    Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K et al (2000) Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 283(8):1031–1037PubMedCrossRefGoogle Scholar
  29. 29.
    Anderson JR, Paramsothy P, Heilig C, Jamieson DJ, Shah K, Duerr A (2006) Accuracy of Papanicolaou test among HIV-infected women. Clin Infect Dis 42(4):562–568PubMedCrossRefGoogle Scholar
  30. 30.
    Branca M, Rossi E, Alderisio M, Migliore G, Morosini PL, Vecchione A et al (2001) Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women. Cytopathology 12(2):84–93PubMedCrossRefGoogle Scholar
  31. 31.
    Robinson WR, Luck MB, Kendall MA, Darragh TM (2003) The predictive value of cytologic testing in women with the human immunodeficiency virus who have low-grade squamous cervical lesions: a substudy of a randomized, phase III chemoprevention trial. Am J Obstet Gynecol 188(4):896–900PubMedCrossRefGoogle Scholar
  32. 32.
    Cejtin HE, Komaroff E, Massad LS, Korn A, Schmidt JB, Eisenberger-Matiyahu D et al (1999) Adherence to colposcopy among women with HIV infection. J Acquir Immune Defic Syndr 22(3):247–252PubMedGoogle Scholar
  33. 33.
    Keiser O, Martinez de Tejada B, Wunder D, Chapuis-Taillard C, Zellweger C, Zinkernagel AS et al (2006) Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study. J Acquir Immune Defic Syndr 43(5):550–555PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Regis Kreitchmann
    • 1
    • 2
  • Halim Bajotto
    • 3
  • Daila Alena Raenck da Silva
    • 1
  • Sandra Costa Fuchs
    • 2
    • 3
  1. 1.Health Municipal DepartmentCenter for STD/AIDS TreatmentPorto AlegreBrazil
  2. 2.Postgraduate Program in Medicine: Medical Sciences, School of MedicineUniversidade Federal do Rio Grande do SulPorto AlegreBrazil
  3. 3.Research Center, Hospital de Clínicas de Porto AlegrePorto AlegreBrazil

Personalised recommendations